Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Uterine Cervical Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Sezary Syndrome 1Radiodermatitis 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pain 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Fatigue 1Endometrial Neoplasms 1Communicable Diseases 1Colorectal Neoplasms 1

Interventions

VCL-CB01 vaccine 1Drug Therapy 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Communicable Diseases × Curcumin × Clear all
NCT02944578 2024-10-29

Topical Curcumin for Precancer Cervical Lesions

Emory University

Phase 2 Terminated
7 enrolled 7 charts

Communicable Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡